Bridge12 Technologies automated high-velocity microsecond freeze hyper-quenching system

Closed Pre-Solicitation Posted

Solicitation number
75N98026Q01138
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
Bethesda, Maryland 20892, United States
Points of contact

Notice details come from SAM.gov. Updated .

About this opportunity

The National Institutes of Health intends to award a sole-source Firm-Fixed-Price Purchase Order to Bridge12 Technologies for an automated high-velocity microsecond freeze hyper-quenching system, with responses due by September 9, 2026. The procurement is predicated on sole-source authority under FAR 6.302-1, citing only one responsible source and no alternative supplies satisfying agency requirements. The system must achieve a dead time of less than or equal to 500 microseconds (0.5 milliseconds) and be compatible with Q-band electron paramagnetic resonance (EPR) applications. This microsecond-scale dead-time capability is a critical minimum technical requirement for capturing short-lived chemical intermediates and transient reaction states; conventional millisecond-scale freeze-quench technology would not adequately resolve these processes. Market research identified Bio-Logic as a commercial competitor in freeze-quench instrumentation, but Bio-Logic's published specifications indicate a minimum dead time of approximately 9 milliseconds, substantially exceeding the Government's 500-microsecond maximum and therefore not meeting minimum requirements. No additional commercial sources offering microsecond rapid mix/freeze-quench systems were identified. The system will be used for Q-band EPR research applications. Performance location is not specified in the pre-solicitation notice.

Notice text

Notice of Intent: Bridge12 Technologies automated high-velocity microsecond freeze hyper-quenching system.

                                                                              (75N98026Q01138)

The National Institutes of Health (NIH) intends to award a Firm-Fixed-Price Purchase Order to Bridge12 Technologies under the authority of FAR 6.302-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements.

The National Institutes of Health (NIH), [Institute/Center], intends to solicit and negotiate on a sole-source basis with Bridge12 Technologies, Inc. for the acquisition of an automated high-velocity microsecond freeze hyper-quenching system for use with Q-band electron paramagnetic resonance (EPR) research applications.

The Government requires a rapid mix/freeze-quench system capable of achieving a dead time of less than or equal to 500 microseconds (≤ 0.5 milliseconds) and compatible with Q-band EPR applications. This rapid dead-time capability is a critical minimum technical requirement because the system will be used to capture and preserve short-lived chemical intermediates and transient reaction states that would not be adequately resolved using conventional millisecond-scale freeze-quench technology.

Market Research

Market research was conducted through review of commercial vendor catalogs, published product specifications, technical literature, and consultation with subject matter experts within the EPR instrumentation community.

The market research identified Bio-Logic as another commercial manufacturer offering freeze-quench instrumentation. However, published Bio-Logic specifications indicate a minimum dead time of approximately 9 milliseconds. This performance is substantially slower than the Government's required maximum dead time of 500 microseconds (0.5 milliseconds) and therefore does not satisfy the Government's minimum technical requirement.

No additional commercial sources were identified through the Government's market research that offer a microsecond rapid mix/freeze-quench system compatible with Q-band EPR applications and capable of achieving the required ≤500-microsecond dead time.

This notice is not a request for competitive quotations. However, any responsible source, including small business concerns (e.g., 8(a), HUBZone, Service-Disabled Veteran-Owned Small Business, Veteran-Owned Small Business, Women-Owned Small Business, and Small Disadvantaged Business), that believes it can satisfy the Government's requirement may submit a capability statement demonstrating its ability to provide a product that meets the Government's minimum technical requirements. Capability statements must include sufficient documentation to establish the ability to furnish an equivalent system.

A determination by the Government not to compete this proposed acquisition based upon responses to this notice is solely within the discretion of the Government.

Responses must be submitted via email to vensonm@mail.nih.gov no later than 9:00 a.m. EDT on September 09, 2026. It is anticipated that an award will be issued approximately five (5) days after the closing date of this notice, provided no acceptable capability statements are received.

Similar open opportunities

Opportunity Agency Set-aside Responses due
Intent to Sole Source - Medical/Scientific Instruments for the Department of Transfusion Medicine, NIH Clinical Center Bethesda, Maryland 20892, United States · NAICS 334516 National Institutes of Health No set-aside
Notice of Intent to Sole Source – AB Sciex LLC Maryland 20892, United States · NAICS 339112 NIH Clinical Center No set-aside
J066--Azenta NitroStore System PM and Support Services NAICS 811210 Veterans Integrated Service Network 4 No set-aside
Octet RH96 preventive service plan for sartorius octet instruments Bethesda, Maryland 20892, United States · NAICS 811210 Office of Logisitics and Acquisition Operations No set-aside
Service Maintenance for MoFlo Astrio AW10012 Bethesda, Maryland 20892, United States · NAICS 811210 Office of Logisitics and Acquisition Operations No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity